Download the full article (PDF) Introduction The emergence of chimeric antigen receptor (CAR)-based immunotherapies has revolutionized the treatment of hematologic malignancies. While CAR-T cell therapies dominate the clinical landscape, enthusiasm is growing for CAR-engineered natural killer (CAR-NK) cells, which leverage the cytotoxic capacity of NK cells with the specificity of CAR constructs. Natural killer (NK) […]
Download the full article (PDF) Introduction The emergence of chimeric antigen receptor (CAR)-based immunotherapies has revolutionized the treatment of hematologic malignancies. While CAR-T cell therapies dominate the clinical landscape, enthusiasm
With the discovery of DNA polymerase in 1956, an enzyme that replicates DNA, a new world of science was opened. The next big discovery in 1970 was Reverse Transcriptase (RT) that uses RNA as a template to synthesize DNA. Later, DNA …
